Skip to content

Clinical trials

Brain Diseases trials in Taiwan

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Diseases Country / region: Taiwan Clear all

13 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20101
20132
20141
20161
20182
20201
20221
20232
20251
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed4
Terminated4
Recruiting3
Active, not recruiting1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company2
GlaxoSmithKline2
TauRx Therapeutics Ltd2
AbbVie1
AstraZeneca1
China Medical University Hospital1
National Taiwan University Hospital1
Neuroscience Trials Australia1
Novartis1
Remedy Pharmaceuticals, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Diseases13
Nervous System Diseases8
Alzheimer Disease7
Central Nervous System Diseases7
Dementia6
Neurodegenerative Diseases6
Mental Disorders4
Cognitive Dysfunction3
Stroke3
Cardiovascular Diseases2

Trials

Showing 1 to 13 of 13. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.